INNT - Innovate Biopharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - INNT (1551986)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
10 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-09-14
INNTPrior Christopher P.CEOP - Purchase$5.82+2002,009+11%+$1,164
2018-09-12
INNTPrior Christopher P.CEOP - Purchase$6.13+5001,809+38%+$3,065
2018-09-07
INNTLaumas SandeepExec COBP - Purchase$6.10+500760,3730%+$3,050
2018-08-30
INNTLaumas SandeepExec COBP - Purchase$5.24+500759,1230%+$2,620
2018-08-30
INNTPrior Christopher P.CEOP - Purchase$5.20+3091,309+31%+$1,607
A
2018-08-28
INNTLaumas SandeepExec COBP - Purchase$4.90+250758,6230%+$1,225
2018-08-28
INNTPrior Christopher P.CEOP - Purchase$4.93+1,0001,000New+$4,930
2018-08-28
INNTLaumas SandeepExec COBP - Purchase$5.01+7501,000+300%+$3,759
M
2018-08-24
INNTAlmenoff June SherieCOO, Chief Medical OfficerP - Purchase$4.92+1,4001,400New+$6,885
M
2016-07-13
INNTClarke David HFormer CEO, DirP - Purchase$0.59+923,5733,136,900+42%+$542,272
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top